How long should I wait to see the results of Skyclarys?

In the Phase 2 MOXIe trial (NCT02255435), whose results supported the approval of Skyclarys by the U.S. Food and Drug Administration, improvements in the function of mitochondria (the so-called powerhouses of cells) and in neurological function were most evident about three months (12 weeks) after starting Skyclarys treatment. Benefits were seen as early as four weeks into therapy. There is, however, no standard timeline for Skyclarys’ benefits, as each person may respond differently to the medication.